Literature DB >> 20151425

Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry.

Joe Lee1, Bang H Hoang, Argyrios Ziogas, Jason A Zell.   

Abstract

BACKGROUND: Ewing sarcoma is a high-grade malignancy that most often occurs in children. Because its occurrence in adults has been historically low, few studies have been published on the epidemiology of Ewing sarcoma in this group of patients. By using data from a large, population-based cancer registry, the authors designed the present study to examine the outcome of children and adult patients with Ewing sarcoma and relevant prognostic factors.
METHODS: A retrospective analysis of Ewing sarcoma patient cases in the California Cancer Registry database was performed to identify incident patient cases diagnosed between 1989-2007. Comparisons were made to examine differences in demographics, disease characteristics, treatment, and survival. Survival analyses were performed using Kaplan-Meier method with log-rank tests and Cox proportional hazards models.
RESULTS: Seven hundred and twenty-five incident patient cases of Ewing sarcoma were identified, including 372 (51.3%) children and 353 (48.7%) adults. Hispanic race was associated with young age (P = .001) and lower socioeconomic status (SES; P = .0001). Pelvic involvement was associated with large tumor size (>8 cm; P < .0001), an increased incidence of metastasis (P < .0002), and poorer survival (P < .0001). After adjusting for clinically relevant factors, statistically significant decreased overall survival was seen with adults (hazard ratio [HR], 1.71; 95% confidence interval [CI], 1.35-2.17), Hispanics (HR, 1.33; 95% CI, 1.01-1.75), metastatic disease (HR, 2.74; 95% CI, 2.14-3.49), large tumor size (HR, 1.65; 95% CI, 1.17-2.34), no surgical treatment, and low SES.
CONCLUSIONS: The authors determined that adult age, Hispanic race, metastatic disease, large tumor size, and low SES are poor prognostic factors for overall survival among Ewing sarcoma patient cases. (c) 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20151425     DOI: 10.1002/cncr.24937

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  59 in total

1.  The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.

Authors:  Yusuke Tsuda; Lei Zhang; Paul Meyers; William D Tap; John H Healey; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2020-05-28       Impact factor: 5.006

2.  Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management.

Authors:  Dagmar Adamkova Krakorova; Katerina Kubackova; Ladislav Dusek; Tomas Tomas; Pavel Janicek; Stepan Tucek; Jana Prausova; Igor Kiss; Iva Zambo
Journal:  Pathol Oncol Res       Date:  2017-08-12       Impact factor: 3.201

3.  Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.

Authors:  Jeremy M Sharib; Jobin Cyrus; Andrew Horvai; Florette K Gray Hazard; John Neuhaus; Katherine K Matthay; Robert Goldsby; Neyssa Marina; Steven G DuBois
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

4.  Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.

Authors:  Mark A Applebaum; Robert Goldsby; John Neuhaus; Steven G DuBois
Journal:  Pediatr Blood Cancer       Date:  2011-12-19       Impact factor: 3.167

5.  Short-term followup after surgical treatment of Ewing's sarcoma.

Authors:  Shishir Rastogi; Ashok Kumar; Himanshu Gupta; Shah Alam Khan; Sameer Bakhshi
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

6.  Identification of Discrete Prognostic Groups in Ewing Sarcoma.

Authors:  Erin E Karski; Elizabeth McIlvaine; Mark R Segal; Mark Krailo; Holcombe E Grier; Linda Granowetter; Richard B Womer; Paul A Meyers; Judy Felgenhauer; Neyssa Marina; Steven G DuBois
Journal:  Pediatr Blood Cancer       Date:  2015-08-10       Impact factor: 3.167

7.  EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations.

Authors:  Robert Beck; Michael J Monument; W Scott Watkins; Richard Smith; Kenneth M Boucher; Joshua D Schiffman; Lynn B Jorde; R Lor Randall; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2012-06

Review 8.  Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management.

Authors:  George Galyfos; Georgios A Karantzikos; Nikolaos Kavouras; Argiri Sianou; Konstantinos Palogos; Konstantinos Filis
Journal:  Indian J Surg       Date:  2015-11-13       Impact factor: 0.656

9.  Treatment of pelvic Ewing's sarcoma: Pros and cons of chemotherapy plus definitive radiotherapy versus surgery.

Authors:  İsmail Eralp Kaçmaz; Burçin Keçeci; Can Doruk Basa; Dündar Sabah
Journal:  Acta Orthop Traumatol Turc       Date:  2020-01       Impact factor: 1.511

Review 10.  Optimal management of Ewing sarcoma family of tumors: recent developments in systemic therapy.

Authors:  Cormac Owens; Lesleigh S Abbott; Abha A Gupta
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.